Literature DB >> 28786228

Impact of CYP3A4 Genotype on Voriconazole Exposure.

Thomas Duflot1,2, Aurélien Schrapp1, Jérémy Bellien1,2, Fabien Lamoureux1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28786228     DOI： 10.1002/cpt.809

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

1.  External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy.

Authors:  Weikun Huang; You Zheng; Huiping Huang; Yu Cheng; Maobai Liu; Nupur Chaphekar; Xuemei Wu
Journal:  Eur J Clin Pharmacol       Date:  2022-06-28       Impact factor: 3.064

Review 2.  Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children.

Authors:  Alice J Hsu; Pranita D Tamma; Brian T Fisher
Journal:  Antimicrob Agents Chemother       Date:  2022-06-29       Impact factor: 5.938

Review 3.  Voriconazole: A Review of Population Pharmacokinetic Analyses.

Authors:  Changcheng Shi; Yubo Xiao; Yong Mao; Jing Wu; Nengming Lin
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

4.  Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis.

Authors:  Sacha Sarfati; Julien Wils; Timothée Lambert; Céline Mory; Laurent Imbert; Gilles Gargala; Hélène Morisse-Pradier; Fabien Lamoureux
Journal:  Pharmaceutics       Date:  2022-07-30       Impact factor: 6.525

5.  Combined Impact of Inflammation and Pharmacogenomic Variants on Voriconazole Trough Concentrations: A Meta-Analysis of Individual Data.

Authors:  Léa Bolcato; Charles Khouri; Anette Veringa; Jan Willem C Alffenaar; Takahiro Yamada; Takafumi Naito; Fabien Lamoureux; Xavier Fonrose; Françoise Stanke-Labesque; Elodie Gautier-Veyret
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

6.  CYP2C19 Phenotype and Body Weight-Guided Voriconazole Initial Dose in Infants and Children after Hematopoietic Cell Transplantation.

Authors:  Takuto Takahashi; Maryam A Mohamud; Angela R Smith; Pamala A Jacobson; Mutaz M Jaber; Abeer F Alharbi; James Fisher; Mark N Kirstein
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

7.  Pharmacogenetic-Pharmacokinetic Interactions in Drug Marketing Authorization Applications via the European Medicines Agency Between 2014 and 2017.

Authors:  Marc Maliepaard; Timi Toiviainen; Marie L De Bruin; Didier Meulendijks
Journal:  Clin Pharmacol Ther       Date:  2020-04-23       Impact factor: 6.875
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.